WIC
VXRT

Woodmont Investment Counsel’s Vaxart VXRT Stock Holding History

Woodmont Investment Counsel’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-3
Closed – – 611
2016
Q3 		$0 Buy
+3
New +$47 ﹤0.01% 741
2016
Q1 		– Sell
-3
Closed – – 552
2015
Q4 		$0 Hold
3
– – ﹤0.01% 565
2015
Q3 		$0 Hold
3
– – ﹤0.01% 573
2015
Q2 		$0 Buy
+3
New +$74 ﹤0.01% 553

Other funds holding VXRT

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $688M AUM 63.4% 1-Year Est. Return

Woodmont Investment Counsel's VXRT Position: Q4 2016 in Review

Woodmont Investment Counsel sold out of Vaxart (VXRT) in Q4 2016, closing a stake of 3 shares.

Woodmont Investment Counsel first reported a position in VXRT in Q2 2015 and held it in 4 quarters. The position peaked at $0 in Q3 2016. 45 funds tracked by Wall St. Rank hold VXRT as of Q4 2016.

  • Woodmont Investment Counsel reported no remaining Vaxart position as of Q4 2016 after selling out during the quarter.
  • Woodmont Investment Counsel sold 3 Vaxart shares in Q4 2016.
  • Woodmont Investment Counsel first reported a position in Vaxart in Q2 2015 and held it in 4 quarters.
  • Woodmont Investment Counsel's Vaxart position peaked at $0 in Q3 2016.
  • 45 funds tracked by Wall St. Rank held Vaxart as of Q4 2016.

Based on Woodmont Investment Counsel's 13F filing for Q4 2016, filed 13 Feb 2017.